That is interesting and could well explain the sorry share price. I knew about the Pope thing, but did not have any idea that there was a problem with the ownership of Gendicine. From everything I have read on the development and trials of Gendicine, it seems to me a no-brainer that SiBiono/Benda would prevail in any such litigation.